+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alkermes plc - logo

Alkermes is a leader in innovative medicines that address the needs of people living with debilitating diseases. Alkermes develops products that are designed to make a meaningful difference in the way patients manage their disease. Alkermes produces innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

Narcolepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Narcolepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Multiple Sclerosis Drugs Market Report 2025 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
5-HT2 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Dopaminergic System Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Dopaminergic System Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Frontotemporal Dementia - Pipeline Insight, 2025 - Product Thumbnail Image

Frontotemporal Dementia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Head And Neck Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028

  • Report
  • April 2018
  • 200 Pages
  • Global
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
From
GABA Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

GABA Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator